Anticoagulant vs. Antiplatelet Therapy in Cryptogenic Stroke

Study Questions:

What is the comparative effectiveness of oral anticoagulation (OAC) compared with antiplatelet therapy (APT) for secondary prevention in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO)?